Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayMay 26, 2021 1:53 pm

NetworkNewsBreaks – Why BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Is ‘One to Watch’

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), based in British Columbia, Canada, and founded in 2017, is a diversified health and wellness beverage and natural products company. BevCanna is focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements. The company offers end-to-end turnkey beverage manufacturing solutions. A recent article discussing this reads, “BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white-label beverage manufacturing solution.” To view the full article,…

Continue Reading

WednesdayMay 26, 2021 1:37 pm

NetworkNewsBreaks – Infobird Software Co. Ltd.’s (NASDAQ: IFBD) Smart Solutions Enable Companies to Focus on Key Operations

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, is building next-level operations in the field of AI-driven customer engagement. Infobird has built a solid reputation as a premier provider of customer engagement software-as-a-service (“SaaS”) solutions in China, leveraging automated and smart capabilities to maximize value for its clients. “The company’s self-developed cloud-native architecture and patented AI technologies, for example, work with a no-code development platform,” reads a recent article. This structure “allows enterprise-building companies to focus on managing their operations as they know best, while relying on the technological expertise of application builders for only the most…

Continue Reading

WednesdayMay 26, 2021 1:26 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Study Promising Candidate in Phase 2 GBM Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is on track to begin a potentially pivotal Phase 2 trial during the second quarter of 2021. This trial of CNSP’s lead drug candidate, Berubicin, in the treatment of glioblastoma multiforme (“GBM”) is currently planned to include up to 243 subjects, randomized 2:1 (162 Berubicin/81 Lomustine) with an interim analysis when 50% of the subjects reach six months in the study. “As the first anthracycline to cross the blood-brain barrier, Berubicin was specifically designed to attack a variety of primary brain cancers and cancers metastatic to the brain,” reads a recent article on the novel candidate.…

Continue Reading

WednesdayMay 26, 2021 1:15 pm

NetworkNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Expands International Reach with 1st Caribbean Distribution Partnership

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the largest independent alkaline water company in the United States, today announced its first Caribbean distribution partnership with SaluVid, a division of TraFon Group, who will market and promote the distribution and sales of the company’s products throughout Puerto Rico and other select Caribbean islands. “Our recently announced brokerage agreement with Bellator Group has already led to a new distribution partnership, further advancing our goal of international expansion this year,” said Ricky Wright, president and CEO of The Alkaline Water Company. “TraFon Group has a strong local network in Puerto Rico, which…

Continue Reading

WednesdayMay 26, 2021 1:12 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Adds Insight, Strengthens Positioning Through Strategic Board Appointment

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently expanded its board of directors with the appointment of Dr. Christina Jenkins. Dr. Jenkins holds capital markets expertise coupled with health care experience through roles that span clinical medicine, venture capital, health plans, and health care systems. Her unique skillset, multivariate perspective and extensive experience have enabled her to create growth-optimizing strategies for health care providers while improving patients’ outcomes. A recent article discussing the appointment quoted POAI CEO J. Melville Engle as saying, “We are very fortunate to have…

Continue Reading

WednesdayMay 26, 2021 1:02 pm

NetworkNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Breakthrough Cancer Visualization Technology Holds Significant Potential

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is looking to change how cystoscopies for bladder cancer are performed with the goal of potentially lowering recurrence rates and ultimately helping improve patients’ lives and long-term outlook. “The company’s i/Blue Imaging System(TM) is a breakthrough cancer visualization technology currently in the manufacturing stage with Lighthouse Imaging, an FDA registered and ISO 13485:2016 certified contract manufacturer located in Maine. The project is on track for completion in 2022,” reads a recent article on the innovative solution. “Imagin Medical’s i/Blue Imaging System has the potential to revolutionize current cystoscopies by showing…

Continue Reading

WednesdayMay 26, 2021 12:35 pm

NetworkNewsBreaks – Music DeFi Pioneer BAND Royalty Featured in NNW Editorial

BAND Royalty today announced its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. The publication, titled, “NFTs Flipping the Script, Bringing Value Back to Music Artists,” discusses the recent emergence of NFTs, or non-fungible tokens, which are breathing life into the industry as musicians get creative with ways to generate revenue and better connect with fans. “An NFT is, in essence, a collectible digital asset, which holds value as a form of cryptocurrency and as a form of art…

Continue Reading

WednesdayMay 26, 2021 12:24 pm

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder, CEO Authors Book Focused on Groundbreaking Work

Vivos Therapeutics (NASDAQ: VVOS) founder and chief medical officer, Dr. G. Dave Singh, DMD, PhD, DDSc, has written a new book with the intent of assisting doctors and dentists in better understanding how to address underlying craniofacial conditions that impact a patient’s overall airway, breathing and sleep health. Titled “Pneumopedics and Craniofacial Epigenetics,” the book covers craniofacial growth and developmental genetics, and addresses the connection between dentofacial anomalies and developmental deficiencies closely associated with downstream conditions such as obstructive sleep apnea (“OSA”). In addition, the book, which is available on Amazon, solidifies the scientific and biological foundation upon which VVOS’s proprietary approach…

Continue Reading

WednesdayMay 26, 2021 12:09 pm

NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Initiation of PALISADE Phase 3 Study of PH94B in SAD

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, is beginning its PALISADE-1 phase 3 trial. The randomized, double-blind, placebo-controlled study is designed to evaluate the efficacy and safety of VTGN’s PH94B (“PH94B”) for the treatment of anxiety in adults with Social Anxiety Disorder (“SAD”). In the announcement, the company noted there is no FDA-approved acute treatment for the disorder. The company plans to include some 200 randomized subjects in the study, which…

Continue Reading

WednesdayMay 26, 2021 11:03 am

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Acquisition of The Lodge Winery & Olive Oil Co.

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced the acquisition of The Lodge Winery & Olive Oil Co. under GTV’s Food & Wine Division, Napa Wine Brands Inc. The Lodge Winery & Olive Oil Co. is an established brand that produces award-winning wines, locally grown and milled, single varietal extra virgin olive oils, as well as a variety of award-winning wine vinegars. “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “We…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000